Thu Oct 24 2024
Dr. Husseini K. Manji reveals the groundbreaking journey of esketamine (SPRAVATO®) from lab to FDA approval. Discover how this rapid-acting antidepressant is reshaping depression treatment and paving the way for future psychedelic medicines.
Get AI-powered summaries and transcripts for any meeting, phone call, or podcast.
Available on iOS, Android, Mac, and Windows
No transcript available.
